Background: Quantitative structure–activity relationship (QSAR) models are central to computer-aided drug discovery and predictive toxicology, but practical adoption is often impeded by ad-hoc tooling, inconsistent validation protocols, and poor reproducibility. Objective: We introduce ProQSAR, a modular, reproducible workbench that formalizes end-to-end QSAR development while permitting independent use of each component. Methods: ProQSAR composes interchangeable modules for standardization, feature generation, splitting (including scaffold- and cluster-aware splits), preprocessing, outlier handling, scaling, feature selection, model training and tuning, statistical comparison, conformal calibration, and applicability-domain assessment. The pipeline can run end-to-end to produce versioned artifact bundles (serialized models, transformers, split indices, provenance metadata) and analyst-oriented reports suitable for deployment and audit. Results: On representative MoleculeNet benchmarks evaluated under Bemis–Murcko scaffold-aware protocols, ProQSAR attains state-of-the-art descriptor-based performance: the lowest mean RMSE across the regression suite (ESOL, FreeSolv, Lipophilicity; mean RMSE 0.658 ± 0.12), including a substantial improvement on FreeSolv (RMSE 0.494 vs. 0.731 for a leading graph method). For classification, ProQSAR achieves the top ROC–AUC on ClinTox (91.4%) while remaining competitive on BACE and BBBP (overall classification average 75.5 ± 11.4). Crucially, all predictions are accompanied by cross-conformal prediction and explicit applicability-domain flags that identify out-of-scope inputs, enabling calibrated, risk-aware decision support. Availability: ProQSAR is released on PyPI, Conda, and Docker Hub; all releases embed full provenance (parameters, package versions, checksums) to ensure reproducibility. Scientific contribution: ProQSAR (i) enforces best-practice, group-aware validation together with formal statistical comparisons across models, (ii) integrates calibrated uncertainty quantification (cross-conformal prediction) and applicability-domain diagnostics for interpretable, risk-aware predictions, and (iii) exposes both a composable developer API and a one-click pipeline that generates deployment-ready artifacts and human-readable reports, demonstrated on representative benchmarks.